Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Population and Prevention Science

Psychologic Distress Is Associated with Cancer-Specific Mortality among Patients with Cervical Cancer

Donghao Lu, Bengt Andrae, Unnur Valdimarsdóttir, Karin Sundström, Katja Fall, Pär Sparén and Fang Fang
Donghao Lu
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
2Faculty of Medicine, Center of Public Health Sciences, School of Health Sciences, University of Iceland, Reykjavík, Iceland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Donghao Lu
  • For correspondence: donghao.lu@ki.se fang.fang@ki.se
Bengt Andrae
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
3Centre for Research and Development, Uppsala University/Region of Gävleborg, Gävle, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bengt Andrae
Unnur Valdimarsdóttir
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
2Faculty of Medicine, Center of Public Health Sciences, School of Health Sciences, University of Iceland, Reykjavík, Iceland.
4Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karin Sundström
5Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karin Sundström
Katja Fall
6Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pär Sparén
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fang Fang
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: donghao.lu@ki.se fang.fang@ki.se
DOI: 10.1158/0008-5472.CAN-19-0116 Published August 2019
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Emerging evidence suggests a role of psychologic factors in the progression of different cancer types. However, it is unclear whether psychologic distress around the time of diagnosis of invasive cervical cancer places patients at a higher risk of cancer-specific mortality, independently of tumor characteristics and treatment modalities. We conducted a nationwide cohort study, including 4,245 patients with newly diagnosed cervical cancer during 2002–2011 in Sweden. Psychologic distress was indicated by a clinical diagnosis of depression, anxiety, or stress reaction and adjustment disorders, or the experience of a stressful life event, including death or severe illness of a family member, divorce, or between jobs, from one year before cancer diagnosis and onwards. We calculated the HRs of cancer-specific mortality among the patients exposed to psychologic distress, compared with unexposed patients, controlling for socioeconomic characteristics and other known prognostic indicators such as tumor and treatment characteristics. We found that patients exposed to psychologic distress had an increased risk of cancer-specific mortality (HR 1.33; 95% CI, 1.14–1.54). The association was primarily driven by distress experienced within one year before or after diagnosis (HR 1.30; 95% CI, 1.11–1.52), but not thereafter (HR 1.12; 95% CI, 0.84–1.49). In summary, our study shows that psychiatric disorders and stressful life events around cancer diagnosis are associated with increased cancer-specific mortality among patients with cervical cancer, independent of tumor characteristics and treatment modality.

Significance: These findings support the integration of psychologic screening and intervention in the clinical management of patients with cervical cancer, particularly around the time of cancer diagnosis.

Introduction

Cervical cancer is the fourth most common cancer and cause of cancer-related death in women worldwide (1). It has a clear etiology in human papillomavirus (HPV) infection (2), while other reported risk factors include smoking (3), risky sexual behavior (4), and socioeconomic disadvantage (5). Clinical characteristics, such as stage and tumor histopathologic features, are currently the most important indicators for cervical cancer prognosis (6).

Emerging evidence from both experimental and epidemiologic studies indicates that psychologic distress might affect the progression of many cancer types (7, 8). For instance, stress accelerates cell proliferation, angiogenesis, and tumor invasion by activating the adrenergic pathway (9, 10). Moreover, chronic stress reduces cellular immunity response via adrenergic and glucocorticoid receptors on immune cells (11). These mechanisms may play a particularly strong role in solid malignancies with infection-related etiology, such as cervical cancer (12).

Few studies have addressed whether psychologic distress is associated with cervical cancer prognosis. The few studies that examined stressful life events, in terms of divorce and bereavement, and cervical cancer survival have led to inconclusive results (13–17), likely due to shortcomings in sample size and the lack of controlling for known prognostic factors. It has been postulated that divorce or widowhood may lead to delayed cancer diagnosis and less treatment, and subsequently a compromised prognosis, among patients with cervical cancer (16).

Patients with cancer are vulnerable to psychologic distress during the disease process. Our recent work has, for example, illustrated that patients receiving a cancer diagnosis were at highly increased risk of several stress-related psychiatric disorders such as depression, anxiety, stress reaction, and adjustment disorders (18). The risk started to increase already during the year before cancer diagnosis and peaked immediately after cancer diagnosis. However, to the best of our knowledge, no studies have specifically examined the association of stress-related disorders, especially the ones diagnosed immediately before and after a cancer diagnosis, with cancer-specific mortality among patients with cervical cancer.

Psychologic distress is challenging to measure. We a priori defined a range of common indicators of severe psychologic distress that are possible to ascertain in Swedish population and health registers, including clinical diagnoses of stress-related psychiatric disorders and stressful life events. We aimed to examine the potential influence of these indicators along the disease course, particularly around the time of cancer diagnosis, on the cancer-specific mortality of patients with cervical cancer, after careful adjustment for multiple sociodemographic and clinical characteristics of these patients.

Patients and Methods

Data sources and patients

As a part of the nationwide Case-Control Audit of Cervical Cancer (19), we utilized the national Swedish Cancer Register (20) to identify all patients (N = 4,533) diagnosed with an invasive cervical cancer from January 1, 2002 through December 31, 2011 in Sweden. Clinical data from all the identified patients were thoroughly reviewed by a senior gynecologist (B. Andrae), who collected and verified information through original medical charts deposited in the clinical departments where patients with cancer had been diagnosed and treated. After this review, we excluded 169 cases of cancers of noncervical origin, 36 cases of nonepithelial origin, 62 cases of noninvasive form, 12 recurrent cases, 7 cases detected on autopsy, and 2 cases with erroneous death records, leaving 4,245 patients in the final cohort. Information on clinical characteristics, including the International Federation of Gynecology and Obstetrics (FIGO) stage, histology, mode of detection, primary treatment, and adjuvant therapy, was also collected from the medical charts.

Using the unique Swedish personal identification numbers, we cross-linked the cohort to the Total Population Register, Education Register, and Longitudinal Integration Database for Health Insurance and Labor Market Studies (LISA by Swedish acronym) and obtained information on demographic characteristics of all patients, such as country of birth, marital status, and educational level. We also linked all patients to the Swedish Patient Register, which has collected nationwide information on hospital discharge records since 1987 and on >80% of hospital-based outpatient specialist visits since 2001 (21). On the basis of this, we calculated the Charlson's comorbidity index (excluding benign and malignant tumors; ref.22) at the time of cancer diagnosis, using the hospital-based care records from 1987 onward. Through record-linkage to the Migration Register and Causes of Death Register, we followed all patients from the date of cancer diagnosis until emigration out of Sweden, death, or December 31, 2012, whichever occurred first.

Stress-related disorders

We specifically studied a composite of three psychiatric disorders, which are relatively common among patients with cervical cancer (23) and potentially related to psychologic distress (18, 24, 25). These included stress reaction and adjustment disorders (the 10th Swedish revision of the International Classification of Disease code [ICD-10]: F43), depression (F32-F33), and anxiety disorder (F40-F41), which are hereafter collectively referred to as stress-related disorders. In contrast to our previous work (18), substance abuse and somatoform/conversion disorders were not included in our current study, because they were very uncommon among patients with cervical cancer. As we aimed to use these disorders as a proxy for severe psychologic distress experienced in relation to the diagnosis and treatment of, or living with, cervical cancer (18), we used newly diagnosed disorders from one year before cancer diagnosis onward as the exposure; with a particular focus on disorders diagnosed within one year before, or after, cancer diagnosis. We identified the clinical diagnoses of these disorders through inpatient or outpatient hospital visits as recorded in the Patient Register, and used the first date of each hospital visit as the date of diagnosis.

Stressful life events

We furthermore studied four types of stressful life events that are both relatively common in the population (26) and known as highly stressful (27–30), including loss of a family member due to death, severe illness of a family member, divorce, and being between jobs.

We identified the parents, spouses, children, and siblings of all patients through the Multi-Generation Register, which contains largely complete familial linkages for all Swedish residents born in 1932 and onward (31). Spouses were identified through a registered common child. We then linked all relatives to the Causes of Death Register to ascertain deaths among, and to the Patient Register to identify severe illnesses of the family members. The selection of severe illnesses was made a priori according to the Global Disease Burden 2004 (32); only illnesses that are relatively common and have a disability weight of ≥0.40 were chosen (see Supplementary Table S1 for ICD codes). Disability weight is the magnitude of health loss related to the illness and ranged from 0 to 1, with 0 implying a state that is equivalent to full health and 1 a state equivalent to death. Divorce was defined as a change of marital status from “married” to “unmarried,” according to the annual marital status recorded in LISA. Between jobs was defined as “actively seeking a job” as recorded in LISA. Among patients with a status of “between jobs,” 98% were previously employed and 91% had a previous job during the preceding two years. We did not study “unemployment” status because not being employed in itself might merely indicate a patient's own choice in relation to poor health.

We studied any first occurrence of these stressful life events from one year before cancer diagnosis onward, as recent events might better reflect a potential emotional burden among the patients (33). In the analysis of severe illness of a family member, we only considered newly diagnosed illnesses of the family members.

Mortality

All deaths occurring among the patients during follow-up was ascertained from the Causes of Death Register, where we identified both the date and underlying cause of death. Our primary outcome was cancer-specific mortality, defined as having cervical cancer (ICD-10: C53) or unspecified uterine cancers (C55) listed as the underlying cause of death (34). A validation study showed that, in this Register, the agreement between death and medical records was 92% for cancer as an underlying cause of death (35). Overall mortality was studied as a secondary outcome.

Statistical analysis

We regarded stress-related disorders and stressful life events as two separate indicators of severe psychologic distress and defined them in a time-varying manner. Patients with either of the indicators during the year before cancer diagnosis were classified as exposed from the date of cancer diagnosis. Patients that were registered with an indicator after cancer diagnosis were first classified as unexposed, and then as exposed from the date of indicator occurrence. Patients without any indicator at any time during one year before cancer diagnosis or thereafter were classified as unexposed throughout.

Psychiatric disorders and stressful life events before cancer diagnosis might lead to delayed diagnosis or differential treatment modes (36, 37), which might partially explain the association between these exposures and mortality. Using binary or multinomial logistic regression models, we, therefore, compared patients with a stress-related disorder or life event during the year before cancer diagnosis to other patients regarding different clinical characteristics, including FIGO stage, histologic type, mode of detection, primary treatment, and adjuvant therapy.

We calculated the crude cancer-specific mortality rates (per 1,000 person-years) among the exposed and unexposed (reference) groups. We then derived HRs of cancer-specific mortality with 95% confidence intervals (CI) from the Cox proportional hazards model, comparing the exposed to the unexposed reference group. The proportional hazards assumption was found to hold for all variables when employing the Schoenfeld residual test. We also examined the associations for any diagnosis of stress-related disorders, any occurrence of stressful life events, as well as for individual psychiatric disorder and individual life event, in separate models. To relieve the concern of including unspecified uterine cancer in the definition of cancer-specific mortality, we performed an additional analysis by excluding deaths with an underlying cause of death coded as unspecified uterine cancers. We then repeated these analyses for overall mortality as a secondary outcome.

There is a greater risk increase of stress-related disorders immediately before and after a cancer diagnosis, compared with thereafter (18), and a varying effect of psychologic distress through the cancer disease continuum has been suggested (7). With a special interest in the one year before or after cancer diagnosis, we examined the studied associations by the timing of the occurrence of stress-related disorders and stressful life events.

To shed light on the potential impact of different characteristics of the stressful life events on the studied associations, we further examined loss of a family member due to death by cause of death (i.e., natural or unnatural cause of death) and severity of the illness of a family member by dichotomizing the disability weights (0.4–0.5 or ≥0.5).

The prevalences of stress-related disorders and stressful life events were different among patients with differing educational level achievement (34.7% among women with primary school education, 47.0% among women with high school education, and 42.9% among women with college and above education). Also, women with lower socioeconomic status may have worse cancer prognosis compared with other women (5). In our data, an increasing level of educational achievement was associated with decreasing cancer-specific mortality (105.9 per 1,000 person-years among women with primary school education, 44.5 among women with high school education, and 30.1 among women with college and above education). We, therefore, considered educational achievement as a confounder for the studied association. In Model A, we adjusted for age at cancer diagnosis, calendar year at diagnosis, highest educational level, country of birth, and number of family members at diagnosis. In Model B, we additionally adjusted for Charlson's comorbidity index, FIGO stage, histology, mode of detection, and treatment modes.

Women with lower socioeconomic status (38) or less social support (39) may furthermore be more vulnerable to psychologic distress, while clinical characteristics are impactful on prognosis. We, therefore, performed stratified analyses by the demographic and clinical characteristics of patients with cervical cancer, using Model B. An interaction term between exposure and the stratification variable was added to the model, and the P value for the interaction term was reported as a significance test for the difference between HRs.

We performed all analyses in STATA 14.2 (StataCorp LP). P < 0.05 indicated statistical significance. This study was approved by the Regional Ethical Review Board in Stockholm, which determined that, due to the population-based nature of the study, written informed consent from the study participants was not required (Dnr 2015/719-32; Dnr 2011/1026-31/4; Dnr 2011/921-32; Dnr 02-556). All investigations were conducted according to the principles in the Declaration of Helsinki.

Results

A total of 1,797 patients (42.3%) were defined as exposed to either stress-related disorders (9.2%) or stressful life events (37.4%) from the year before cancer diagnosis onward (Table 1), of which 860 (48%) occurred within one year before or after diagnosis. The mean age at diagnosis was 53.9 years. The patients were commonly diagnosed at stage IB (39.7%), with tumors of squamous cell origin (72.6%), and were commonly symptomatic (70.8%) at the time of diagnosis. In total, 56.4% of patients underwent surgery, whereas 51.2% and 31.8% of the patients received radiotherapy and chemotherapy, respectively. During the follow-up (mean ± SD = 4.4 ± 3.1 years), 1,392 (32.8%) patients died, 1,005 (72.2%) of which died due to cervical cancer specifically.

View this table:
  • View inline
  • View popup
Table 1.

Demographic and clinical characteristics of patients with cervical cancer: a nationwide cohort study in Sweden, 2002–2012

Patients with indications of psychologic distress (either a stress-related disorder or a stressful life event) during the year before diagnosis did not differ substantially from patients without such indications, in terms of FIGO stage, histologic type, or cancer detection pattern (Table 2). Patients with a stress-related disorder during the year before cancer diagnosis were, however, more likely to receive palliative treatment compared with other patients.

View this table:
  • View inline
  • View popup
Table 2.

Associations of stress-related disorders or stressful life events occurred during one year before cancer diagnosis with clinical characteristics: a nationwide cohort study in Sweden, 2002–2012

Patients with indications of psychologic distress (either a stress-related disorder or a stressful life event) from one year before cancer diagnosis onward had an increased risk of cancer-specific mortality (HR 1.33; 95% CI, 1.14–1.54), compared with unexposed patients (Fig. 1). After further adjustment for clinical characteristics, the association was slightly attenuated but remained statistically significant (HR 1.26; 95% CI, 1.08–1.46). The risk was particularly elevated in those exposed to stress-related disorders (HR 1.55; 95% CI, 1.20–1.99), and was also elevated in those exposed to stressful life events (HR 1.20; 95% CI, 1.02–1.41). Such association was noted for all individual stress-related disorders and life events, although some associations were not statistically significant. Similar estimates were noted after excluding deaths with an underlying cause of death coded as unspecified uterine cancers from the definition of cause-specific death (5.5% of all cancer-specific deaths; Supplementary Fig. S1). Similar but somewhat weaker associations were found for overall mortality (Supplementary Fig. S2).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Associations of stress-related disorders or stressful life events from one year before cancer diagnosis onward with the risk of cancer-specific mortality among patients with cervical cancer: a nationwide cohort study in Sweden, 2002–2012. N, number of events; Rate, mortality rate, per 1,000 person-years. *HRs were adjusted for age at diagnosis, calendar year at diagnosis (2002–2004, 2005–2007, or 2008–2011), educational level (primary school or unknown, high school, or college+), country of birth (Nordic or non-Nordic), and family size at diagnosis. §HRs were adjusted for age at diagnosis, calendar year at diagnosis (2002–2004, 2005–2007, or 2008–2011), educational level (primary school or unknown, high school, or college+), country of birth (Nordic or non-Nordic), family size at diagnosis, FIGO stage (IA, IB, II, or III+), histology (squamous cell cancer or others), mode of detection (screening or symptom), mode of treatment (surgery only, chemo/radiotherapy only, surgery plus chemo/radioherapy, or palliative care), and Charlson comorbidity index (0 or ≥1).

Stress-related disorders or stressful life events experienced within one year before or after diagnosis (HR 1.30; 95% CI, 1.11–1.52), but not thereafter (HR 1.12; 95% CI, 0.84 – 1.49), were associated with a higher risk of cancer-specific mortality (Fig. 2; Supplementary Table S2). Stress-related disorders were associated with an increased risk of cancer-specific mortality regardless of when the disorder was diagnosed, whereas stressful life events were associated with a higher risk only when they occurred within the year before or after cancer diagnosis. A similar pattern was noted for overall mortality (Supplementary Fig. S3 and Table S2).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Associations of stress-related disorders or stressful life events from one year before cancer diagnosis onward with the risk of cancer-specific mortality among patients with cervical cancer by the timing of occurrence of psychiatric disorders or life events: a nationwide cohort study in Sweden, 2002–2012. In Model A, HRs were adjusted for age at diagnosis, calendar year at diagnosis (2002–2004, 2005–2007, or 2008–2011), educational level (primary school or unknown, high school, or college+), country of birth (Nordic or non-Nordic), and family size at diagnosis. In Model B, HRs were additionally adjusted for FIGO stage (IA, IB, II, or III+), histology (squamous cell cancer or others), mode of detection (screening or symptom), mode of treatment (surgery only, chemo/radiotherapy only, surgery plus chemo/radiotherapy, or palliative care), and Charlson comorbidity index (0 or ≥1).

A greater HR of cancer-specific mortality was suggested in those with loss of a family member due to unnatural causes, compared with that in those with loss due to natural causes (Table 3). Having been exposed to severe illness of a family member with a disability weight of over, but not below, 0.5 was clearly associated with an increased risk of cancer-specific mortality. A similar pattern was observed for overall mortality (Supplementary Table S3).

View this table:
  • View inline
  • View popup
Table 3.

Associations of subtypes of loss and severe illness of a family member from one year before cancer diagnosis onward with the risk of cancer-specific mortality among patients with cervical cancer: a nationwide cohort study in Sweden, 2002–2012

The associations of stress-related disorders or stressful life events with cancer-specific mortality were not clearly modified by demographic or clinical characteristics (Supplementary Table S4).

Discussion

In this nationwide cohort study of women with cervical cancer, we found that psychologic distress, defined as either a clinical diagnosis of stress-related disorders or an occurrence of stressful life events around the time of cancer diagnosis, was associated with an increased risk of cervical cancer-specific mortality. For the first time, we showed that these associations were independent of known prognostic indicators of cervical cancer, including tumor characteristics, mode of diagnosis, and treatment.

Stress-related disorders are common among patients with cancer, both after cancer diagnosis (24, 40, 41) and during the year before cancer diagnosis (18). Except for depression, few studies have so far specifically examined these disorders in relation to cancer-specific mortality among patients with cancer (42, 43). Our findings show that clinical diagnoses of depression, anxiety, and stress reaction and adjustment disorders were not uncommon among patients with cervical cancer (9.2%). To our knowledge, no other study has reported the combined prevalence of clinically diagnosed stress-related disorders among patients with cervical cancer. A previous study from South Korea used administrative databases to ascertain the diagnosis of depression among patients with cervical cancer and reported a prevalence of 7.9% (44). The slightly lower prevalence of depression in this study (4.9%) is likely because only clinical diagnoses made by specialists or during in-patient care were included in our study. Stress-related disorders, either collectively or individually, were associated with 66%–139% excess risks of cancer-specific mortality. Most of these associations were attenuated to some extent but remained statistically significant after further adjustment for tumor characteristics, diagnostic mode, and treatment modality, lending support to the hypothesis that the influence of psychologic distress on cervical cancer survival is independent of other clinical factors. Stress-related disorders diagnosed immediately before or after cancer diagnosis might be a proxy of a severe stress response to clinical workup, the final cancer diagnosis (18), and a dramatically impaired quality of life after a diagnosis of cervical cancer (45). This subgroup of vulnerable patients could be detected during this specific time window.

Stressful life events have also been linked to increased mortality among patients with cancer (8). Previous studies have examined the association of individual events, for example, bereavement and divorce (13–15), with cervical cancer survival. Here, we found that four major life events, including bereavement, severe illness of a family member, divorce, and being between jobs, were prevalent among patients with cervical cancer (37.4%). While the collective prevalence of these life events has not been documented before, the prevalence of individual events has been reported among patients with cervical cancer. For example, divorce or separation was reported to have a prevalence of 15%–22% (14, 16), whereas the prevalence of bereavement (loss of a child or spouse due to death) was reported as 2%–14% (13, 14, 16), among patients with cervical cancer. However, these numbers cannot be compared directly with ours, because we ascertained these events around the time of cancer diagnosis and thereafter, whereas the other studies usually measured one individual event before cancer diagnosis. Collectively, these life events were associated with a 20% elevated risk of cancer-specific mortality. These results on bereavement and divorce are in line with findings of previous Nordic studies (13–15).

Experimental studies suggest that psychologic distress modulates tumor growth and progression through the dysregulation of oncogenes, angiogenesis, inflammation, and host immune responses operated by the hypothalamic–pituitary–adrenal axis and sympathetic nervous system (7). For instance, the adrenergic signaling pathway activated by stress may upregulate VEGF to increase angiogenesis around the tumor and subsequently facilitate tumor growth (46). Chronic stress may also reduce T-cell–proliferative response through the adrenergic and glucocorticoid receptors on immune cells, leading to decreased cellular immunity and immunosurveillance (11). In addition to such direct modulation, psychologic distress may also influence cancer survival through delayed diagnosis or altered treatment (36, 37). Few studies have disentangled the contributions of differential tumor characteristics, diagnostic mode, and cancer treatment from the link of psychologic distress to cancer-specific mortality (36, 47). For instance, the increased cancer-specific mortality reported among patients with gynecologic cancer with preexisting psychiatric disorders was attributed to a lower rate of surgery and radiotherapy (36). This is partly supported by our results, where patients with a stress-related disorder during the year before cancer diagnosis appeared more likely to receive palliative treatment. However, the association of stress-related disorders or life events with an increased risk of cancer-specific mortality remained robust after extensive adjustment for tumor characteristics, and mode of diagnosis/treatment.

Stressful life events occurring during the early course (i.e., the year before and the year after cancer diagnosis) were associated with a greater risk increase of cancer-specific mortality, compared with life events occurring thereafter. Together with the slightly stronger association noted for localized cancer (IB stage) compared with higher stage cancer, this finding suggests that psychologic distress plays a more significant role in cancer-specific mortality among patients with early-stage and localized tumors. This is also supported by accumulating experimental evidence indicating that psychologic distress might specifically facilitate the spread of tumor cells from the local site through surrounding blood and lymph vessels (7, 48). The temporal pattern of the associations between stress-related disorders and cancer-specific mortality was even more complicated. Although similar magnitude of associations was found for stress-related disorders diagnosed during the year before and the year after cancer diagnosis, as for stressful life events, a stronger association was noted for stress-related disorders occurring more than one year after diagnosis. The latter finding might be partly explained by the fact that stress-related disorders occurring during the later disease course of cancer might represent other aspects of disease characteristics (e.g., failure of the primary treatment and disease relapse), suggesting potential reverse causality.

One major merit of our study is the large-scale nationwide cohort design with complete follow-up, as well as prospective and independent nature of data collection, largely limiting the common sources of bias. The rich information on clinical characteristics allowed us to disentangle the direct influence of psychologic distress on cancer-specific mortality, from the influence through tumor characteristics, diagnosis, and cancer treatment.

The chosen proxies for severe psychologic distress might have only partially illustrated the psychologic distress a patient with cervical cancer is likely to experience. Because we used specialist-care–based in-patient and outpatient diagnoses to define stress-related disorders, we may have missed less symptomatic patients that were not attended by specialists, as well as individuals with psychiatric symptoms that had not sought care at all. Also, patients with other stressful life events such as financial hardship due to sickness absence were classified as unexposed. However, such misclassifications most likely would have led to an attenuated magnitude of the studied associations. Our study did not address earlier stressful exposures during the life course, which may influence cervical cancer survival. However, we chose to focus on distress around cancer diagnosis as such has the most direct implications for oncologic practice through, for example, early surveillance and intervention.

While our previous work (49) suggested a role of psychologic distress in the risk of oncogenic infection of human papillomavirus, cervical dysplasia, and invasive cervical cancer, these findings further indicate a role of psychologic distress in cervical cancer–specific mortality. If verified in independent populations, these findings may lend support to a specific and continuous role of psychologic distress in the etiology/pathogenesis of cervical cancer (49). Furthermore, given that 42% of patients with cervical cancer experienced a stress-related disorder or stressful life event along the disease course, psychologic intervention may be considered as an integral component in cervical cancer care.

In conclusion, stress-related disorders and stressful life events among patients with cervical cancer were associated with an increased risk of cancer-specific mortality. These associations were independent of tumor characteristics, diagnostic mode, and treatment modality.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Authors' Contributions

Conception and design: D. Lu, U. Valdimarsdóttir, F. Fang

Development of methodology: D. Lu, U. Valdimarsdóttir, F. Fang

Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): B. Andrae, U. Valdimarsdóttir, K. Sundström, P. Sparén

Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): D. Lu, U. Valdimarsdóttir, K. Sundström, K. Fall, P. Sparén, F. Fang

Writing, review, and/or revision of the manuscript: D. Lu, B. Andrae, U. Valdimarsdóttir, K. Sundström, K. Fall, P. Sparén, F. Fang

Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): F. Fang

Study supervision: U. Valdimarsdóttir, P. Sparén, F. Fang

Acknowledgments

We thank Dr. Walter Ryd, University of Gothenburg, for pathologic review. We also acknowledge the contributions to data collection and management on this project of Sara Nordqvist Kleppe, Pouran Almstedt, and the late Peter Olausson. This work is supported by the Swedish Cancer Society (grant no. CAN 2017/322), Swedish Research Council for Health, Working Life, and Welfare (grant no. 2017-00531), and the Karolinska Institutet (Stockholm, Sweden; Partial Financing for New Doctoral Student, Senior Researcher Award, and Strategic Research Program in Epidemiology Young Investigator Award).

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Footnotes

  • Note: Supplementary data for this article are available at Cancer Research Online (http://cancerres.aacrjournals.org/).

  • Prior Presentation: The abstract was presented at the 34th Annual Meeting of International Society for Traumatic Stress Studies, November 8–10, 2018, Washington, D.C.

  • Cancer Res 2019;79:3965–72

  • Received January 9, 2019.
  • Revision received April 8, 2019.
  • Accepted June 4, 2019.
  • Published first June 28, 2019.
  • ©2019 American Association for Cancer Research.

References

  1. 1.↵
    1. Bray F,
    2. Ferlay J,
    3. Soerjomataram I,
    4. Siegel RL,
    5. Torre LA,
    6. Jemal A
    . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Schiffman M,
    2. Castle PE,
    3. Jeronimo J,
    4. Rodriguez AC,
    5. Wacholder S
    . Human papillomavirus and cervical cancer. Lancet 2007;370:890–907.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Appleby P,
    2. Beral V,
    3. Berrington de Gonzalez A,
    4. Colin D,
    5. Franceschi S,
    6. et al.
    International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006;118:1481–95.
    OpenUrlCrossRefPubMed
  4. 4.↵
    International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. Cancer Epidemiol Biomarkers Prev 2009;18:1060–9.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Jensen KE,
    2. Hannibal CG,
    3. Nielsen A,
    4. Jensen A,
    5. Nohr B,
    6. Munk C,
    7. et al.
    Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994–2003. Eur J Cancer 2008;44:2003–17.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Cohen PA,
    2. Jhingran A,
    3. Oaknin A,
    4. Denny L
    . Cervical cancer. Lancet 2019;393:169–82.
    OpenUrl
  7. 7.↵
    1. Lutgendorf SK,
    2. Andersen BL
    . Biobehavioral approaches to cancer progression and survival: mechanisms and interventions. Am Psychol 2015;70:186–97.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Chida Y,
    2. Hamer M,
    3. Wardle J,
    4. Steptoe A
    . Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol 2008;5:466–75.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Chang A,
    2. Le CP,
    3. Walker AK,
    4. Creed SJ,
    5. Pon CK,
    6. Albold S,
    7. et al.
    beta2-Adrenoceptors on tumor cells play a critical role in stress-enhanced metastasis in a mouse model of breast cancer. Brain Behav Immun 2016;57:106–15.
    OpenUrlCrossRef
  10. 10.↵
    1. Sloan EK,
    2. Priceman SJ,
    3. Cox BF,
    4. Yu S,
    5. Pimentel MA,
    6. Tangkanangnukul V,
    7. et al.
    The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res 2010;70:7042–52.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Lutgendorf SK,
    2. Lamkin DM,
    3. DeGeest K,
    4. Anderson B,
    5. Dao M,
    6. McGinn S,
    7. et al.
    Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients. Brain Behav Immun 2008;22:890–900.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Fang F,
    2. Fall K,
    3. Valdimarsdottir U
    . Stress and cancer: Nordic pieces to the complex puzzle. Eur J Epidemiol 2015;30:525–7.
    OpenUrl
  13. 13.↵
    1. Kvikstad A,
    2. Vatten LJ
    . Risk and prognosis of cancer in middle-aged women who have experienced the death of a child. Int J Cancer 1996;67:165–9.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Kvikstad A,
    2. Vatten LJ,
    3. Tretli S
    . Widowhood and divorce in relation to overall survival among middle-aged Norwegian women with cancer. Br J Cancer 1995;71:1343–7.
    OpenUrlPubMed
  15. 15.↵
    1. Li J,
    2. Johansen C,
    3. Olsen J
    . Cancer survival in parents who lost a child: a nationwide study in Denmark. Br J Cancer 2003;88:1698–701.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Patel MK,
    2. Patel DA,
    3. Lu M,
    4. Elshaikh MA,
    5. Munkarah A,
    6. Movsas B
    . Impact of marital status on survival among women with invasive cervical cancer: analysis of population-based surveillance, epidemiology, and end results data. J Low Genit Tract Dis 2010;14:329–38.
    OpenUrlPubMed
  17. 17.↵
    1. Bjorge T,
    2. Kravdal O
    . Reproductive factors and prognosis of uterine cervical cancer in Norway. Br J Cancer 1996;74:1843–6.
    OpenUrlPubMed
  18. 18.↵
    1. Lu D,
    2. Andersson TM,
    3. Fall K,
    4. Hultman CM,
    5. Czene K,
    6. Valdimarsdottir U,
    7. et al.
    Clinical diagnosis of mental disorders immediately before and after cancer diagnosis: a nationwide matched cohort study in Sweden. JAMA Oncol 2016;2:1188–96.
    OpenUrl
  19. 19.↵
    1. Lei J,
    2. Ploner A,
    3. Lagheden C,
    4. Eklund C,
    5. Nordqvist Kleppe S,
    6. Andrae B,
    7. et al.
    High-risk human papillomavirus status and prognosis in invasive cervical cancer: a nationwide cohort study. PLoS Med 2018;15:e1002666.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Barlow L,
    2. Westergren K,
    3. Holmberg L,
    4. Talback M
    . The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009;48:27–33.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Ludvigsson JF,
    2. Andersson E,
    3. Ekbom A,
    4. Feychting M,
    5. Kim JL,
    6. Reuterwall C,
    7. et al.
    External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450.
    OpenUrlCrossRefPubMed
  22. 22.
    1. Quan H,
    2. Li B,
    3. Couris CM,
    4. Fushimi K,
    5. Graham P,
    6. Hider P,
    7. et al.
    Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 2011;173:676–82.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Mehnert A,
    2. Brahler E,
    3. Faller H,
    4. Harter M,
    5. Keller M,
    6. Schulz H,
    7. et al.
    Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol 2014;32:3540–6.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Mitchell AJ,
    2. Chan M,
    3. Bhatti H,
    4. Halton M,
    5. Grassi L,
    6. Johansen C,
    7. et al.
    Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011;12:160–74.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Klengel T,
    2. Binder EB
    . Epigenetics of stress-related psychiatric disorders and gene x environment interactions. Neuron 2015;86:1343–57.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Holmes TH,
    2. Rahe RH
    . The social readjustment rating scale. J Psychosom Res 1967;11:213–8.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Hagedoorn M,
    2. Sanderman R,
    3. Buunk BP,
    4. Wobbes T
    . Failing in spousal caregiving: The “identity-relevant stress” hypothesis to explain sex differences in caregiver distress. Br J Health Psychol 2002;7:481–94.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Chen JH,
    2. Bierhals AJ,
    3. Prigerson HG,
    4. Kasl SV,
    5. Mazure CM,
    6. Jacobs S
    . Gender differences in the effects of bereavement-related psychological distress in health outcomes. Psychol Med 1999;29:367–80.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Johnson DR,
    2. Wu J
    . An empirical test of crisis, social selection, and role explanations of the relationship between marital disruption and psychological distress: a pooled time-series analysis of four-wave panel data. J Marriage Fam 2002;64:211–24.
    OpenUrlCrossRef
  30. 30.↵
    1. Smari J,
    2. Arason E,
    3. Hafsteinsson H,
    4. Ingimarsson S
    . Unemployment, coping and psychological distress. Scand J Psychol 1997;38:151–6.
    OpenUrlPubMed
  31. 31.↵
    1. Ekbom A
    . The Swedish Multi-generation Register. Methods Mol Biol 2011;675:215–20.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Mathers C,
    2. Fat DM,
    3. Boerma JT
    . The global burden of disease: 2004 update. Geneva, Switzerland: WHO Press; 2008.
  33. 33.↵
    1. Lehto US,
    2. Ojanen M,
    3. Dyba T,
    4. Aromaa A,
    5. Kellokumpu-Lehtinen P
    . Impact of life events on survival of patients with localized melanoma. Psychother Psychosom 2012;81:191–3.
    OpenUrlPubMed
  34. 34.↵
    1. Andrae B,
    2. Andersson TM,
    3. Lambert PC,
    4. Kemetli L,
    5. Silfverdal L,
    6. Strander B,
    7. et al.
    Screening and cervical cancer cure: population based cohort study. BMJ 2012;344:e900.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Johansson LA,
    2. Bjorkenstam C,
    3. Westerling R
    . Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995. J Clin Epidemiol 2009;62:1202–9.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Kisely S,
    2. Crowe E,
    3. Lawrence D
    . Cancer-related mortality in people with mental illness. JAMA Psychiatry 2013;70:209–17.
    OpenUrl
  37. 37.↵
    1. Kravdal O
    . The impact of marital status on cancer survival. Soc Sci Med 2001;52:357–68.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Cohen S,
    2. Janicki-Deverts D
    . Who's stressed? Distributions of psychological stress in the United States in probability samples from 1983, 2006, and 2009. J Appl Soc Psychol 2012;42:1320–34.
    OpenUrlCrossRef
  39. 39.↵
    1. Heinrichs M,
    2. Baumgartner T,
    3. Kirschbaum C,
    4. Ehlert U
    . Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry 2003;54:1389–98.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Mitchell AJ,
    2. Ferguson DW,
    3. Gill J,
    4. Paul J,
    5. Symonds P
    . Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol 2013;14:721–32.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Bidstrup PE,
    2. Christensen J,
    3. Mertz BG,
    4. Rottmann N,
    5. Dalton SO,
    6. Johansen C
    . Trajectories of distress, anxiety, and depression among women with breast cancer: looking beyond the mean. Acta Oncol 2015;54:789–96.
    OpenUrl
  42. 42.↵
    1. Zhu J,
    2. Fang F,
    3. Sjolander A,
    4. Fall K,
    5. Adami HO,
    6. Valdimarsdottir U
    . First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study. Ann Oncol 2017;28:1964–9.
    OpenUrl
  43. 43.↵
    1. Iglay K,
    2. Santorelli ML,
    3. Hirshfield KM,
    4. Williams JM,
    5. Rhoads GG,
    6. Lin Y,
    7. et al.
    Impact of preexisting mental illness on all-cause and breast cancer-specific mortality in elderly patients with breast cancer. J Clin Oncol 2017;35:4012–8.
    OpenUrl
  44. 44.↵
    1. Park B,
    2. Youn S,
    3. Yi KK,
    4. Lee SY,
    5. Lee JS,
    6. Chung S
    . The Prevalence of depression among patients with the top ten most common cancers in South Korea. Psychiatry Investig 2017;14:618–25.
    OpenUrl
  45. 45.↵
    1. Herzog TJ,
    2. Wright JD
    . The impact of cervical cancer on quality of life–the components and means for management. Gynecol Oncol 2007;107:572–7.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Thaker PH,
    2. Han LY,
    3. Kamat AA,
    4. Arevalo JM,
    5. Takahashi R,
    6. Lu C,
    7. et al.
    Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006;12:939–44.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Saito-Nakaya K,
    2. Bidstrup PE,
    3. Nakaya N,
    4. Frederiksen K,
    5. Dalton SO,
    6. Uchitomi Y,
    7. et al.
    Stress and survival after cancer: a prospective study of a Finnish population-based cohort. Cancer Epidemiol 2012;36:230–5.
    OpenUrlPubMed
  48. 48.↵
    1. Le CP,
    2. Nowell CJ,
    3. Kim-Fuchs C,
    4. Botteri E,
    5. Hiller JG,
    6. Ismail H,
    7. et al.
    Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination. Nat Commun 2016;7:10634.
    OpenUrlCrossRef
  49. 49.↵
    1. Lu D,
    2. Sundstrom K,
    3. Sparen P,
    4. Fall K,
    5. Sjolander A,
    6. Dillner J,
    7. et al.
    Bereavement is associated with an increased risk of HPV infection and cervical cancer: An Epidemiological Study in Sweden. Cancer Res 2016;76:643–51.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Cancer Research: 79 (15)
August 2019
Volume 79, Issue 15
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Psychologic Distress Is Associated with Cancer-Specific Mortality among Patients with Cervical Cancer
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Psychologic Distress Is Associated with Cancer-Specific Mortality among Patients with Cervical Cancer
Donghao Lu, Bengt Andrae, Unnur Valdimarsdóttir, Karin Sundström, Katja Fall, Pär Sparén and Fang Fang
Cancer Res August 1 2019 (79) (15) 3965-3972; DOI: 10.1158/0008-5472.CAN-19-0116

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Psychologic Distress Is Associated with Cancer-Specific Mortality among Patients with Cervical Cancer
Donghao Lu, Bengt Andrae, Unnur Valdimarsdóttir, Karin Sundström, Katja Fall, Pär Sparén and Fang Fang
Cancer Res August 1 2019 (79) (15) 3965-3972; DOI: 10.1158/0008-5472.CAN-19-0116
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Patients and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Racial/Ethnic Disparities in Mortality of TNBC
  • HLA and Risk for Cancer
  • Oral Contraceptive and Breast, Ovarian, and Endometrial Cancers
Show more Population and Prevention Science
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement